Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Endostatin with Chemotherapy in Advanced NSCLC
NCT01527864Phase 2Unknown
- Sponsor
- Protogen
- Start
- May 2011
- Primary completion
- Dec 2012
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated recombinant human endostatin in non-small cell lung cancer (NSCLC), sponsored by Protogen. Status: unknown.
02
Drugs
pegylated recombinant human endostatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01527864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01527864.